158 related articles for article (PubMed ID: 24867796)
21. Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women.
Song JF; Jing ZZ; Hu W; Su YX
Genet Mol Res; 2013 Sep; 12(3):3279-85. PubMed ID: 24065669
[TBL] [Abstract][Full Text] [Related]
22. Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women.
Erdogan MO; Yıldız H; Artan S; Solak M; Taşcıoğlu F; Dündar U; Eser B; Colak E
Osteoporos Int; 2011 Apr; 22(4):1219-25. PubMed ID: 20532479
[TBL] [Abstract][Full Text] [Related]
23. The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.
Peng Y; Sheng X; Xue F; Qian Y
Medicine (Baltimore); 2018 Dec; 97(51):e13507. PubMed ID: 30572450
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of ERα and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women.
Kurt O; Yilmaz-Aydogan H; Uyar M; Isbir T; Seyhan MF; Can A
Mol Biol Rep; 2012 Jun; 39(6):6723-30. PubMed ID: 22311020
[TBL] [Abstract][Full Text] [Related]
25. [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].
Wang C; He JW; Qin YJ; Zhang H; Hu WW; Liu YJ; Zhang ZL
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2958-62. PubMed ID: 20137703
[TBL] [Abstract][Full Text] [Related]
26. Relation of JAGGED 1 and collagen type 1 alpha 1 polymorphisms with bone mineral density in Chinese postmenopausal women.
Zhang LQ; Liu H; Huang XF
Int J Clin Exp Pathol; 2014; 7(10):7142-7. PubMed ID: 25400810
[TBL] [Abstract][Full Text] [Related]
27. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
[TBL] [Abstract][Full Text] [Related]
28. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.
Zhang C; Ma J; Chen G; Fu D; Li L; Li M
Osteoporos Int; 2015 Dec; 26(12):2803-10. PubMed ID: 26055357
[TBL] [Abstract][Full Text] [Related]
30. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
31. Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan.
Chen HY; Chen WC; Hsu CD; Tsai FJ; Tsai CH; Li CW
Osteoporos Int; 2001 Dec; 12(12):1036-41. PubMed ID: 11846330
[TBL] [Abstract][Full Text] [Related]
32. Association of vitamin D receptor gene polymorphism (TaqI and Apa1) with bone mineral density in North Indian postmenopausal women.
Ahmad I; Jafar T; Mahdi F; Ameta K; Arshad M; Das SK; Waliullah S; Rizvi I; Mahdi AA
Gene; 2018 Jun; 659():123-127. PubMed ID: 29559350
[TBL] [Abstract][Full Text] [Related]
33. Influence of polymorphisms in insulin-like growth factor-1 on the risk of osteoporosis in a Chinese postmenopausal female population.
Li F; Xing WH; Yang XJ; Jiang HY; Xia H
Int J Clin Exp Pathol; 2015; 8(5):5727-32. PubMed ID: 26191288
[TBL] [Abstract][Full Text] [Related]
34. Impact of genetic variants of IL-6, IL6R, LRP5, ESR1 and SP7 genes on bone mineral density in postmenopausal Mexican-Mestizo women with obesity.
Méndez JP; Rojano-Mejía D; Coral-Vázquez RM; Coronel A; Pedraza J; Casas MJ; Soriano R; García-García E; Vilchis F; Canto P
Gene; 2013 Oct; 528(2):216-20. PubMed ID: 23891823
[TBL] [Abstract][Full Text] [Related]
35. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
36. Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
Xiao X; Roohani D; Wu Q
Osteoporos Int; 2018 Aug; 29(8):1807-1814. PubMed ID: 29713799
[TBL] [Abstract][Full Text] [Related]
37. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
38. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Mencej-Bedrač S; Preželj J; Marc J
Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
[TBL] [Abstract][Full Text] [Related]
39. Association of a -1997G-->T polymorphism of the collagen Ialpha1 gene with bone mineral density in postmenopausal Japanese women.
Yamada Y; Ando F; Niino N; Shimokata H
Hum Biol; 2005 Feb; 77(1):27-36. PubMed ID: 16114814
[TBL] [Abstract][Full Text] [Related]
40. -643C > T RANKL gene polymorphism is associated with osteoporosis in Tunisian postmenopausal women.
Sassi R; Sahli H; Cheour E; Sellami S; El Gaaied ABA
Climacteric; 2017 Aug; 20(4):374-378. PubMed ID: 28453307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
